Bharat Rasayan Limited (BHARATRAS) Fair Value & Analysis
Basic Materials · IN · Market cap ₹22.7B
Fair value as of: Aug 2, 2026
From 26 valuation models · updated 11 days ago
Share price −1.2% over the past month.
Below-average quality, and screening another 22% overvalued on our models.
What matters now
- Weak quality (44/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The model range is unusually wide (₹566.66 to ₹1,557). The outcome hinges heavily on assumptions, so read the point estimate with caution.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 2, 2026.
How to read this chart
60‑month range ₹1,210 – ₹330,799 · fair‑value band ₹566.66 – ₹1,557 · the ₹1,360 price screens above the ₹1,062 fair value. Dashed = 300-day average. As of Aug 2, 2026.
Analysis
Bharat Rasayan Limited (BHARATRAS) currently trades at ₹1,360, while our model-based Fair Value estimate is ₹1,062, implying the stock looks roughly 21.9% overvalued today. The Quality Score stands at 44/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Bharat Rasayan Limited generated revenue of ₹12.4B at a net margin of 11.7%. Revenue grew 0.5% year over year. It earns a return on equity of 12.1%. The balance sheet holds a net cash position of ₹218M. Fundamentals as of Aug 2, 2026
Our scenario range runs from ₹566.66 (bear case) to ₹1,557 (bull case); at ₹1,360, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Basic Materials peers we cover trades at -13% fair-value upside, at -22%, BHARATRAS screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: Growth Earnings (₹1,612) versus Dividend Discount (₹6.04). Highest evidence: Growth DCF (80).
Notify me when BHARATRAS reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 2, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 45 · Market factors (momentum, volatility) 22
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Bharat Rasayan Limited engages in the manufacture and sale of technical grade pesticides and intermediates in India. It offers insecticides, herbicides, fungicides, and intermediates. The company also exports its products through multinational agrochemical companies and other traders.
Full company description
Bharat Rasayan Limited engages in the manufacture and sale of technical grade pesticides and intermediates in India. It offers insecticides, herbicides, fungicides, and intermediates. The company also exports its products through multinational agrochemical companies and other traders. Bharat Rasayan Limited was incorporated in 1989 and is based in New Delhi, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Bharat Rasayan Limited reported revenue of ₹12.4B in FY2026 versus ₹13.0B in FY2022, a compound −1.0%/yr. Reported net income was ₹1.5B in FY2026, compounding −4.6%/yr from FY2022.
of which total revenue +9.7 pp · buybacks/dilution −3.2 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
BHARATRAS screens 22% overvalued. Compare with Corteva, Inc →
Peer Group
Agricultural Inputs · 178 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Agricultural Inputs median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Aug 2, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Corteva, Inc CTVA | $86.07 | $27.81 | -68% |
| Nutrien Ltd NTR | C$94.23 | C$81.69 | -13% |
| Qinghai Salt Lake Industry Co 000792 | ¥24.93 | ¥21.26 | -15% |
| CF Industries Holdings CF | $119.19 | $161.00 | +35% |
| SABIC Agri-Nutrients Company 2020 | 122.90 SAR | 127.31 SAR | +4% |
| Yara International ASA YAR | kr 451.30 | kr 67.25 | -85% |
| Yunnan Yuntianhua Co 600096 | ¥30.17 | ¥42.12 | +40% |
| Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 | ¥42.59 | ¥38.01 | -11% |
| Coromandel International Limited COROMANDEL | ₹2,034 | ₹1,129 | -44% |
| UPL Limited UPL | ₹594.75 | ₹387.06 | -35% |
Compare Bharat Rasayan Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Bharat Rasayan Limited (BHARATRAS) overvalued or undervalued?
What is the fair value of BHARATRAS?
What is the quality score of BHARATRAS?
What is the revenue of Bharat Rasayan Limited (BHARATRAS)?
What is the net profit margin of BHARATRAS?
Does Bharat Rasayan Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Bharat Rasayan Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.